Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Arena eyes obesity drug refiling by end of 2011
Reuters
Wed, 12/22/10 - 08:55 am
Arena Pharmaceuticals
obesity
FDA
Vivus applies to market obesity drug Qnexa in EU
Marketwatch
Mon, 12/20/10 - 12:31 pm
Vivus
Qnexa
obesity
EU
Europe
Diet Drug Rally: Orexigen, Vivus, Arena
TheStreet.com
Wed, 12/8/10 - 12:27 pm
obesity
Orexigen
Vivus
Arena Pharmaceuticals
Contrave
Qnexa
Orexigen Wins U.S. Panel’s Backing for New Diet Pill
Bloomberg Businessweek
Tue, 12/7/10 - 06:05 pm
obesity
Orexigen
advisory panels
FDA
Contrave
Orexigen Therapeutics: FDA Panel Live Blog
TheStreet.com
Tue, 12/7/10 - 07:56 am
FDA
advisory panels
Orexigen
Contrave
obesity
Orexigen braces for advisory panel's Contrave review
Fierce Biotech
Mon, 12/6/10 - 05:04 pm
Orexigen
Contrave
FDA
advisory panels
obesity
Advisory Votes Against Expanding Use of GSK’s, Merck’s Prostate Drugs: Biotech's Latest Tribulations
Seeking Alpha
Sun, 12/5/10 - 11:52 am
GSK
Merck
Avodart
enlarged prostate
prostate cancer
Proscar
Orexigen
obesity
Contrave
Novartis
JNJ
Merck KGaA
FDA: Proposed Weight Loss Drug Contrave Raises Blood Pressure
WSJ Online
Fri, 12/3/10 - 11:06 am
FDA
obesity
Contrave
hypertension
Orexigen
Orexigen's Diet Pill Has Unclear Benefits, an FDA Staff Review Indicates
Bloomberg
Fri, 12/3/10 - 08:46 am
Orexigen
FDA
Contrave
obesity
Orexigen: Don't Count Contrave Out Yet
Seeking Alpha
Fri, 12/3/10 - 06:45 am
FDA
obesity
Orexigen
Contrave
Arena Pharmaceuticals
Vivus
Orexigen Options Suggest Contrave Diet Pill May Avoid Arena, Vivus Delays
Bloomberg
Thu, 12/2/10 - 10:17 am
Orexigen
options
Contrave
obesity
Vivus
Arena Pharmaceuticals
Allergan Lap-Band Effective in Treating More Obese People, FDA Staff Says
Bloomberg
Wed, 12/1/10 - 11:29 am
Allergan
obesity
Lap-Band
FDA
Orexigen: Contrave FDA Panel Preview
TheStreet.com
Tue, 11/30/10 - 08:02 am
FDA
advisory panels
Orexigen
Contrave
obesity
Arena Pharmaceuticals
Vivus
Obesity Drug Risks Prompt New Wide-Reaching EU Drug Data Disclosure Rule
Bloomberg
Fri, 11/19/10 - 11:14 am
obesity
Europe
Acomplia
Sanofi
Arena touts new obesity data as it campaigns for quick OK
Fierce Biotech
Tue, 11/9/10 - 08:59 am
obesity
Arena Pharmaceuticals
diabetes
Diet Drug Optimism Lifts Shares of Vivus
NY Times
Sat, 10/30/10 - 12:14 pm
Vivus
Qnexa
obesity
Vivus Gains on Potential to Win U.S. Clearance for Obesity Drug Next Year
Bloomberg
Fri, 10/29/10 - 11:49 am
Qnexa
FDA
obesity
Vivus
Whither Diet Pills? Why The FDA Keeps Saying No
Pharmalot
Fri, 10/29/10 - 11:46 am
Vivus
Qnexa
obesity
diet pills
Arena Pharmaceuticals
FDA
Vivus Fails to Win U.S. Approval for Diet Pill Qnexa on Safety Concerns
Bloomberg
Thu, 10/28/10 - 10:17 pm
FDA
diet drugs
Qnexa
Vivus
obesity
Long Odds Seen For Diet Drugs
WSJ Online
Tue, 10/26/10 - 12:37 pm
obesity
Arena Pharmaceuticals
Eisai
Orexigen
Contrave
Pages
« first
‹ previous
…
38
39
40
41
42
43
44
45
46
…
next ›
last »